The treatment of Benign Paroxysmal Positional Vertigo & Weight Loss with vitamins

Benign Paroxysmal Positional Vertigo and Weight Loss: Mitamins custom make quality formulas for the treatment of Benign Paroxysmal Positional Vertigo & Weight Loss with vitamins. A Benign Paroxysmal Positional Vertigo & Weight Loss formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Benign Paroxysmal Positional Vertigo and Weight Loss

  • Amount Per Serving
    % DV
    Vitamin C
    500
    mg
    833%
    Vitamin E
    400
    IU
    1333%
    Thiamin
    100
    mg
    6667%
    Riboflavin
    100
    mg
    5882%
    Niacin
    100
    mg
    500%
    Vitamin B6
    100
    mg
    5000%
    Folate
    400
    mcg
    100%
    Vitamin B12
    100
    mcg
    1667%
    Biotin
    100
    mcg
    33%
    Pantothenic Acid
    100
    mg
    1000%
    Choline Bitartrate
    100
    mg
    *
  • Amount Per Serving
    % DV
    Inositol
    100
    mg
    *
    PABA
    100
    mg
    *
    Ginkgo Extract
    120
    mg
    *
    Green Tea Extract
    50
    mg
    *
    L-Carnitine
    50
    mg
    *
    L-Glutamine
    50
    mg
    *
    Conjugated Linoleic Acid
    50
    mg
    *
    Pyruvate
    50
    mg
    *
    Cayenne Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Benign Paroxysmal Positional Vertigo and Weight Loss
Serving Size:4-5

Benign Paroxysmal Positional Vertigo and Weight Loss Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Italian-German Research Team Discovers Cellular Marker For Multiple Sclerosis
In their search for the cellular and molecular causes of multiple sclerosis, an Italian-German research team has identified a subgroup of protective immune cells (suppressor cells) which are strikingly reduced in number in patients with this nervous system disorder. These suppressor cells are characterized by a specific surface marker, called CD39, and degrade ATP, an energy carrier released from damaged tissues.
Pharmasset Commences Dosing In 28-Day Combination Study Of R7128 With Pegasys(R) Plus Copegus(R) For Hepatitis C
Pharmasset, Inc. (Nasdaq: VRUS) has commenced dosing in a Phase 1 study of R7128 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in up to 75 treatment-naive patients chronically infected with hepatitis C virus (HCV) genotype 1. R7128 is a prodrug of PSI-6130, an oral cytidine nucleoside analog polymerase inhibitor of HCV that is being developed through Pharmasset's collaboration with Roche.
This information concerning the support of Benign Paroxysmal Positional Vertigo and Weight Loss treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments